Main news

Aggressive glucose control no benefit in CV surgery patients with T2D Chicago, IL - An aggressive approach to glucose control for diabetic patients undergoing elective cardiac surgery does not improve outcomes or reduce length of stay—and may even be harmful, the Neurological Outcomes in Diabetics Undergoing Cardiovascular Surgery (NODS) trial suggests

Stress CT perfusion matches SPECT for detecting myocardial ischemia Montreal, QC - In stress testing using regadenoson (Lexiscan, Astellas), detection rates of myocardial ischemia were similar with less invasive computed-tomography (CT) perfusion imaging compared with the reference method, single-photon-emission CT (SPECT) imaging, in a phase 2 trial.

Perioperative beta-blocker controversy begins again with new meta-analysis London, UK - The debate over the perioperative use of beta-blockers in noncardiac surgery is flaring up once again with the publication of a new meta-analysis suggesting their use increases the risk of death [1]. In an analysis that excluded discredited clinical trials, investigators report that treatment of patients undergoing noncardiac surgery with beta-blockers resulted in a statistically significant 27% increased mortality risk.

ACE inhibitors may slow cognitive decline Cork, Ireland and Hamilton, ON - Centrally acting ACE inhibitors reduce the rate of cognitive decline in patients with dementia, regardless of blood-pressure levels at the time of their hypertension diagnosis, a new study has found

Some antihypertensives linked to breast-cancer risk Boston, MA - The first observational study of long-term antihypertensive use and breast-cancer risk found that calcium-channel blockers (CCBs) were associated with a more than twofold increased risk, while ACE inhibitors appeared to be associated with a reduced risk.

Early surgery bests "watchful waiting" in severe MR patients without symptoms Rochester, MN - Patients with severe mitral regurgitation (MR) without a class I indication for surgical intervention fared significantly better when treated with surgery than patients who underwent "watchful waiting" while treated with medical therapy, according to the results of a new analysis, published in the August 14, 2013 issue of the Journal of the American Medical Association

Who, what, when? Questions over Heartware ENDURANCE trial Framingham, MA - One of the principal investigators for the pivotal ENDURANCE trial testing HeartWare International’s ventricular-assist device (VAD) as destination therapy says he still plans to present the full results late next year.

Physician continuity important in reducing HF outcomes Edmonton, AB - Patients hospitalized with heart failure have significantly better clinical outcomes if they are followed up with a physician early after hospital discharge, a new study shows [1]. Physician continuity, however—defined as seeing a doctor already familiar with the patient—was associated with significantly better outcomes than seeing an unfamiliar physician.

Journal “Metabolism and somatic diseases”
Journal “Metabolism and somatic diseases” “Metabolism and somatic diseases” is a medical journal for specialists in different fields of medicine – from internal medicine to interventional cardiology, from basic science to engineering of medical equipment . The journal is published four times a year in two languages (English and Russian) in printed and electronic forms. Printed version is available for free. All issues of journal are available for free on official website

AMPLIFY: Apixaban in acute VTE as effective but safer than standard anticoagulation Amsterdam, the Netherlands - The oral factor Xa inhibitor apixaban (Eliquis, Pfizer/Bristol-Myers Squibb) was as effective as standard enoxaparin plus warfarin in treating acute venous thromboembolism (VTE) in a large randomized trial, one in which treatment with apixaban also led to a 69% drop in risk of major bleeding complications

What's New in the AHA/ASA Secondary Stroke Prevention Guidelines?
What's New in the AHA/ASA Secondary Stroke Prevention Guidelines? Clinical Context Risk for recurrent stroke or TIA is high but can be lowered by appropriate secondary stroke prevention. As secondary stroke prevention strategies have improved in recent years, cohort studies have shown decreased rates of recurrent stroke and transient ischemic attack (TIA).

ESC Congress 2021
ESC Congress 2021 ESC Congress is first and foremost a celebration of science. It's all about challenging and inspiring cardiovascular professionals to discover and deliver the best care possible to their patients. It’s widely regarded as THE annual cardiology event in the calendar.

Editorial Activity

cardiology book

HIGHER COFFEE INTAKE TIED TO LOWER MORTALITY RISK Higher coffee intake is linked to significantly lower risk for death, two large studies confirm. The benefit was found in diverse European populations, as well as across different racial/ethnic groups, researchers report in articles published online today in Annals of Internal Medicine. Because coffee is one of the most popular drinks in the United States and worldwide, the public health effect of coffee intake could be substantial, even if the effect on an individual is small. Despite mounting evidence for the health and mortality benefits of coffee consumption, the relationship between coffee intake and mortality in different European populations in which coffee preparation methods vary has been unclear. Similarly, data on coffee drinking among nonwhite populations were lacking.

FOCUSED ISSUE ON ADVANCES IN CARDIOVASCULAR DISEASE PREVENTION: INTERVIEW WITH PROF. NATHAN D. WONG AND PROV. IAN GRAHAM A very focused issue on “Advances in Cardiovascular Disease Prevention” has been published in Cardiovascular Diagnosis and Therapy(CDT). It was our honor to invite its Guest-editors Prof. Nathan D. Wong and Prof. Ian Graham for an E-interview. Prof. Nathan Wong is a cardiovascular epidemiologist and Professor and Director, Heart Disease Prevention Program, Division of Cardiology at the University of California, Irvine in California. He holds MPH and PhD degrees in epidemiology from YaleUniversity. He is a past president (2010–2012) of the American Society for Preventive Cardiology. He is also a fellow of the AmericanCollege of Cardiology, American Heart Association, National Lipid Association, and American Society for Preventive Cardiology and is the current treasurer of the Pacific Lipid Association, and is on the board of directors of the InterAmerican Heart Federation and California Chapter of the AmericanCollege of Cardiology. He also serves on the Member Services and Credentialing Committee and Prevention of Cardiovascular Disease Committee of the AmericanCollege of Cardiology and is past chair of the American Heart Association Prevention Science Subcommittee.

INFLAMATION MAY EXPLAIN MORTALITY-RISK LINK TO TV WATCHING Prolonged television viewing is associated with an increased mortality risk, including from cardiovascular disease (CVD), that may be at least partially mediated by inflammatory markers, suggest results from a large UK cohort study[1]. The findings, which were published online on June 9, 2017 inAtherosclerosis, demonstrate for the first time that over 15% of the association between mortality and increased TV viewing may be explained by C-reactive protein and fibrinogen levels. Dr Mark Hamer (National Centre for Sport and Exercise Medicine, East Midlands, Loughborough, UK) and colleagues note that previous research has shown that prolonged sitting is linked to the expression of genes associated with inflammatory responses. "Fibrinogen, the strongest predictor of mortality in the present study, may also have relevance in terms of elevated risk of vascular conditions, particularly venous thrombosis," they write. "Recent experimental data demonstrated increases in plasma fibrinogen with prolonged uninterrupted sitting that was attenuated with active breaks." While the researchers note that the study design does not allow the temporal relationship between TV viewing and the biomarkers to be determined, previous analyses of the same cohort revealed a prospective association between TV viewing and changes in inflammatory markers.

THE GENDER GAP IN CARDIOLOGY IS EMBARRASSING Since women make up about half of all medical students, the glaring gender gap in cardiology deserves attention. Dr Robert Harrington of Stanford called the dearth of women in cardiology a talent issue for our field. In a tweet, he noted that women make up 45% to 47% of internal medicine residents but less than 20% of cardiology fellows. And it"s worse in the lab-based subspecialties, where <10% of interventional cardiology or electrophysiology fellows are women.

Professor David Wood, WHF President, on participating in the 70th World Health Assembly
Professor David Wood, WHF President, on participating in the 70th World Health Assembly Today marks the opening of the 70th World Health Assembly (WHA), one of the highlights of the global health calendar. At this annual conference, Ministers of Health, civil society and World Health Organization (WHO) experts will meet to discuss the most pressing health issues of our time, including cardiovascular disease (CVD). As President of the World Heart Federation, I am delighted to welcome a large delegation of member partners, members, Board and staff to the event. Through our leading position in cardiovascular health, we aim to raise the profile of CVD to ensure that global health policies meet the needs of patients and our global membership.

Genetic Risk Could Guide Heart Disease Prevention
Genetic Risk Could Guide Heart Disease Prevention The use of genetic sequencing to identify which patients would benefit most from aggressive statin therapy for the primary prevention of a heart attack could soon be a clinical reality. And the discovery of genetic mutations associated with cardiovascular disease — but not linked to any known risk factors — opens the possibility of novel therapies to help people cut the risk for future events. "Among those at high genetic risk, statins confer a greater benefit for primary prevention of coronary heart disease," said Sekar Kathiresan, MD, from Massachusetts GeneralHospital in Boston and the Broad Institute in Cambridge.

On behalf of Cardioprogress Foundation let us sincerely congratulate you with the World Heart Day!
On behalf of Cardioprogress Foundation let us sincerely congratulate you with the World Heart Day! On behalf of Cardioprogress Foundation let us sincerely congratulate you with the World Heart Day! World Heart Day is celebrated annually starting from 1999, more than in 100 countries around the globe in the last Sunday of September. And in 2011, the World Heart Day. And from 2011 it has its own confirmed date- the 29th of September. Events, that take place during the World Heart Day are attract attention to the problem of cardiovascular diseases, it"s the world"s biggest intervention against these conditions. It’s utterly important to show the world the importance of healthy life style, and the influence of bad habits on the cardiovascular system.

Trump Pick for CMS Would Ease Up on Physicians
Trump Pick for CMS Would Ease Up on Physicians Seema Verma, MPH, President Donald Trump"s choice to head the Centers for Medicare & Medicaid Services (CMS), has mixed feelings about electronic health record (EHR) systems. It"s just one example of how she"s on the same page with many physicians regarding healthcare. "My doctor…is staring at her computer instead of looking at me," the healthcare policy consultant told the US Senate Committee on Finance during her confirmation hearing yesterday. Verma"s comment came in response to a question about the future of the CMS incentive program for meaningful use of EHRs, much criticized by physicians for turning them into data entry clerks. She also recounted seeing signs in physician waiting rooms that apologized for schedule delays due to EHR implementation. Yet another tech challenge she cited was the lack of EHR interoperability, which prevents different programs from freely exchanging data.